Get the Stockscreener App
38.09
10.59%
-4.51
Tectonic Therapeutic Inc stock is traded at $38.09, with a volume of 199.98K.
It is down -10.59% in the last 24 hours and down -18.21% over the past month.
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease.
See More
Previous Close:
$42.60
Open:
$42.22
24h Volume:
199.98K
Relative Volume:
0.82
Market Cap:
$628.46M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-29.65%
1M Performance:
-18.21%
6M Performance:
+136.00%
1Y Performance:
+0.00%
1-Day Range:
$37.86
$42.77
1-Week Range:
$37.86
$56.00
52-Week Range:
$15.00
$61.07
Tectonic Therapeutic Inc Stock (TECX) Company Profile
Name
Tectonic Therapeutic Inc
Sector
Industry
Phone
(339) 666-3320
Address
490 ARSENAL WAY, WATERTOWN
Compare TECX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TECX
Tectonic Therapeutic Inc
|
38.09 | 628.46M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
473.85 | 123.91B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
715.03 | 78.94B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
650.78 | 39.98B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
274.88 | 35.89B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
118.75 | 28.75B | 3.30B | -501.07M | 1.03B | -2.1146 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-20-24 | Initiated | Raymond James | Outperform |
| Aug-22-24 | Initiated | Wells Fargo | Overweight |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| Jun-24-24 | Initiated | TD Cowen | Buy |
| Dec-18-23 | Downgrade | Mizuho | Buy → Neutral |
| Jan-05-22 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-19-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-15-21 | Initiated | BTIG Research | Buy |
| May-27-21 | Initiated | Needham | Buy |
| Mar-09-21 | Initiated | Barclays | Overweight |
| Mar-02-21 | Initiated | Stifel | Hold |
| Nov-11-20 | Initiated | Berenberg | Buy |
| Mar-31-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jun-27-19 | Initiated | Mizuho | Buy |
| Apr-05-19 | Initiated | Janney | Buy |
| Oct-10-18 | Initiated | Guggenheim | Buy |
| Oct-02-18 | Reiterated | H.C. Wainwright | Buy |
| Sep-17-18 | Initiated | H.C. Wainwright | Buy |
| Jul-16-18 | Initiated | Wedbush | Outperform |
| Jul-16-18 | Initiated | Wells Fargo | Outperform |
View All
Tectonic Therapeutic Inc Stock (TECX) Latest News
Tectonic Therapeutic Inc (TECX) Stock: A Review of the Recent Movement - The News Heater
Petri Dish: VC firm's new $340M seed fund; Watertown biotech raises $185M - The Business Journals
Brokerages Set Tectonic Therapeutic (NASDAQ:TECX) Target Price at $80.50 - Defense World
Tectonic announces ~$185M capital raise - MSN
Tectonic Therapeutic (NASDAQ:TECX) Shares Down 3.2%Here's Why - MarketBeat
Tectonic: Expansion Of TX45 Candidate Possible After Positive Interim Data (NASDAQ:TECX) - Seeking Alpha
Tectonic secures $185 million in private equity funding - MSN
Tectonic Therapeutic (NASDAQ:TECX) Given New $112.00 Price Target at Wells Fargo & Company - MarketBeat
TECX (Tectonic Therapeutic Inc) may reap gains as insiders became active recently - Knox Daily
Tectonic Therapeutic (NASDAQ:TECX) Trading 6.7% Higher After Analyst Upgrade - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Reaches New 52-Week HighTime to Buy? - MarketBeat
Tectonic Therapeutic to Raise $185 Million Via Private Investment in Public Equity Financing - Marketscreener.com
Tectonic Therapeutic Secures $185 Million in PIPE Deal - TipRanks
Tectonic Therapeutic announces $185M private placement - TipRanks
Tectonic Therapeutic (NASDAQ:TECX) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
Tectonic Announces $185 Million Private Placement - The Bakersfield Californian
Major Funding Alert: Tectonic Therapeutic Lands $185M from Elite Investors at Premium Price - StockTitan
Tectonic Therapeutic (NASDAQ:TECX) Price Target Raised to $112.00 - Defense World
Tectonic Therapeutic reports ‘positive’ data from Phase 1b trial for TX45 - TipRanks
Tectonic Therapeutic (NASDAQ:TECX) Trading Down 13.3%Should You Sell? - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Stock Price Down 13.3%Here's What Happened - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Shares Up 6.7% on Analyst Upgrade - Defense World
Tectonic jumps on positive data from early-stage trial for lead asset - MSN
Wall Street Rally: Dow Hits One-Month High as IBM Surges, Microsoft Declines – Market - HPBL
Tectonic’s Plates Shift On Positive Phase Ib PH-HFpEF Data - News & Insights
Wall Street relaxin as Tectonic plates up phase Ib heart data - BioWorld Online
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Tectonic Therapeutic: Stock Spikes On Heart Failure Data — Why I See Further Upside (TECX) - Seeking Alpha
Stock market news: Foxx Development Holdings +220.76%, Tectonic Therapeutic +117.03% among top gainers during mid day trading - Business Upturn
Tectonic Therapeutic Shares Hit 52-Week High After Positive Trial Data - MarketWatch
Tectonic Therapeutic (TECX) Stock Soars On Positive Clinical Trial Update - Stocks Telegraph
Stock market today: Foxx Development Holdings +243.94%, Alpha Modus Holdings +142.21% among top gainers in early trading - Business Upturn
Dow Jumps Over 100 Points; Tesla Earnings Miss Views - Benzinga
Tectonic Therapeutic Shares Soar Pre-Bell Following Interim Data From TX45 Trial -January 30, 2025 at 09:20 am EST - Marketscreener.com
Tectonic stock jumps on trial data for TX45 (TECX:NASDAQ) - Seeking Alpha
Tectonic Therapeutic stock soars on positive trial data By Investing.com - Investing.com Canada
Tectonic Therapeutic stock soars on positive trial data - Investing.com
Tectonic Therapeutic Reports Positive Interim Results for TX45 - TipRanks
Tectonic Therapeutic Announces Positive Interim Data from - GlobeNewswire
Game-Changing Results: This New Drug Could Transform Pulmonary Hypertension Treatment - StockTitan
Eli Lilly trial update on kidney drug hurts Tectonic - MSN
Tectonic stock plunges on Eli Lilly trial update (TECX:NASDAQ) - Seeking Alpha
Leerink says Eli Lilly news causes concern about Tectonic’s TX45 success - TipRanks
Tectonic Therapeutic (NASDAQ:TECX) Shares Up 8.2%Here's What Happened - MarketBeat
Clarius Group LLC Invests $468,000 in Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Tectonic Therapeutic Highlights Pipeline and Financial Strength - TipRanks
Brokerages Set Tectonic Therapeutic (NASDAQ:TECX) Price Target at $72.25 - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Shares Down 8.8%Should You Sell? - MarketBeat
We Think Tectonic Therapeutic (NASDAQ:TECX) Can Afford To Drive Business Growth - Simply Wall St
Tectonic Therapeutic Inc Stock (TECX) Financials Data
There is no financial data for Tectonic Therapeutic Inc (TECX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Tectonic Therapeutic Inc Stock (TECX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Schwabish Marc | Chief Business Officer |
Dec 09 '24 |
Option Exercise |
2.38 |
2,000 |
4,760 |
2,000 |
| McNamara Peter | Chief Scientific Officer |
Dec 03 '24 |
Option Exercise |
2.38 |
3,500 |
8,330 |
14,188 |
| SPRINGER TIMOTHY A | Director |
Oct 22 '24 |
Buy |
33.59 |
300,000 |
10,077,000 |
4,096,764 |
| SPRINGER TIMOTHY A | Director |
Sep 26 '24 |
Buy |
28.82 |
50,000 |
1,440,829 |
3,796,764 |
| Leonard Braden Michael | 10% Owner |
May 13 '24 |
Buy |
1.25 |
469,753 |
585,546 |
4,471,380 |
| Leonard Braden Michael | 10% Owner |
May 14 '24 |
Buy |
1.30 |
296,882 |
385,947 |
4,768,262 |
0.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):